JELI: Joint Embedding-classifier Learning for improved Interpretability
We mentioned in a previous blog post the issues in machine learning for drug repurposing related to imbalanced drug-disease outcomes -that is, sparse results...
Posts by Category
blog
Five insights from our large-scale benchmark
By now, you should be aware that our objectives are to overcome the high cost, duration, and risk issues in traditional de novo drug development pipelines. T...
A large-scale benchmark for collaborative filtering applied to drug repurposing
2025 starts with another of our papers [1] being currently in press at Scientific Reports!
JELI: an interpretable classifier
The second chapter of the RECeSS project aims at providing interpretable classification (into positive and negative associations) of drug-disease pairs. We a...
We released our first paper!
We are glad to announce that our first (tool) paper has been accepted at Journal of Open Source Software !
Release of the benchscofi package
The Python package benchscofi for the benchmark of collaborative filtering-based approaches to drug repurposing is out!
Release of the stanscofi package
We introduce our Python package stanscofi for the development of collaborative filtering-based drug repurposing algorithms!
New drug repurposing datasets
We are really excited to present the first two drug repurposing datasets for collaborative filtering produced during the RECeSS project!
Launch of the RECeSS project website!
We are pleased to launch the blog associated with the Robust Explainable Controllable Standard for drug Screening (RECeSS) project!
flash lecture
Introduction to pathway enrichment (II)
This post is the second part of this one. We will use the same running example on epileptic mice exposed to a CSF1R inhibitor. In the previous post, one appr...
Introduction to pathway enrichment (I)
The second chapter of the RECeSS project aims at providing interpretable classification (into positive and negative associations) of drug-disease pairs. But ...
Introduction to PU learning
Drug repurposing is a paradigm for drug development, where drug discovery focuses on already commercialized molecules. The key idea is that if those molecule...